ID   FTCD_HUMAN              Reviewed;         541 AA.
AC   O95954; B9EGD0; Q86V03; Q9HCT4; Q9HCT5; Q9HCT6; Q9UHJ2;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=Formimidoyltransferase-cyclodeaminase;
DE   AltName: Full=Formiminotransferase-cyclodeaminase;
DE            Short=FTCD;
DE   AltName: Full=LCHC1;
DE   Includes:
DE     RecName: Full=Glutamate formimidoyltransferase;
DE              EC=2.1.2.5;
DE     AltName: Full=Glutamate formiminotransferase;
DE     AltName: Full=Glutamate formyltransferase;
DE   Includes:
DE     RecName: Full=Formimidoyltetrahydrofolate cyclodeaminase;
DE              EC=4.3.1.4;
DE     AltName: Full=Formiminotetrahydrofolate cyclodeaminase;
GN   Name=FTCD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; C; D AND E).
RC   TISSUE=Kidney;
RX   PubMed=10773664;
RA   Solans A., Estivill X., de la Luna S.;
RT   "Cloning and characterization of human FTCD on 21q22.3, a candidate
RT   gene for glutamate formiminotransferase deficiency.";
RL   Cytogenet. Cell Genet. 88:43-49(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 396-541.
RX   PubMed=10029623; DOI=10.1016/S0016-5085(99)70186-1;
RA   Lapierre P., Hajoui O., Homberg J.-C., Alvarez F.;
RT   "Formiminotransferase cyclodeaminase is an organ-specific autoantigen
RT   recognized by sera of patients with autoimmune hepatitis.";
RL   Gastroenterology 116:643-649(1999).
RN   [4]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND CENTRIOLE ASSOCIATION.
RX   PubMed=16534631; DOI=10.1007/s00418-006-0166-5;
RA   Hagiwara H., Tajika Y., Matsuzaki T., Suzuki T., Aoki T., Takata K.;
RT   "Localization of Golgi 58K protein (formiminotransferase
RT   cyclodeaminase) to the centrosome.";
RL   Histochem. Cell Biol. 126:251-259(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-316 AND SER-386,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-549 (ISOFORM C), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   VARIANTS FIGLU-URIA CYS-135 AND PRO-299, AND VARIANT GLU-438.
RX   PubMed=12815595; DOI=10.1002/humu.10236;
RA   Hilton J.F., Christensen K.E., Watkins D., Raby B.A., Renaud Y.,
RA   De La Luna S., Estivill X., MacKenzie R.E., Hudson T.J.,
RA   Rosenblatt D.S.;
RT   "The molecular basis of glutamate formiminotransferase deficiency.";
RL   Hum. Mutat. 22:67-73(2003).
CC   -!- FUNCTION: Folate-dependent enzyme, that displays both transferase
CC       and deaminase activity. Serves to channel one-carbon units from
CC       formiminoglutamate to the folate pool.
CC   -!- FUNCTION: Binds and promotes bundling of vimentin filaments
CC       originating from the Golgi. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 5-formimidoyltetrahydrofolate + L-glutamate =
CC       tetrahydrofolate + N-formimidoyl-L-glutamate.
CC   -!- CATALYTIC ACTIVITY: 5-formyltetrahydrofolate + L-glutamate =
CC       tetrahydrofolate + N-formyl-L-glutamate.
CC   -!- CATALYTIC ACTIVITY: 5-formimidoyltetrahydrofolate = 5,10-
CC       methenyltetrahydrofolate + NH(3).
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- PATHWAY: Amino-acid degradation; L-histidine degradation into L-
CC       glutamate; L-glutamate from N-formimidoyl-L-glutamate (transferase
CC       route): step 1/1.
CC   -!- PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.
CC   -!- SUBUNIT: Homooctamer, including four polyglutamate binding sites.
CC       The subunits are arranged as a tetramer of dimers, and form a
CC       planar ring-shaped structure (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8N6L0:CCDC155; NbExp=3; IntAct=EBI-10192648, EBI-749265;
CC       Q9NPJ6:MED4; NbExp=3; IntAct=EBI-10192648, EBI-394607;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome, centriole
CC       {ECO:0000269|PubMed:16534631}. Golgi apparatus {ECO:0000250}.
CC       Note=More abundantly located around the mother centriole.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=A;
CC         IsoId=O95954-1; Sequence=Displayed;
CC       Name=C;
CC         IsoId=O95954-2; Sequence=VSP_004260;
CC         Note=Contains a phosphoserine at position 549.
CC         {ECO:0000244|PubMed:24275569};
CC       Name=D;
CC         IsoId=O95954-3; Sequence=VSP_004259;
CC       Name=E;
CC         IsoId=O95954-4; Sequence=VSP_004257, VSP_004258;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- DISEASE: Glutamate formiminotransferase deficiency (FIGLU-URIA)
CC       [MIM:229100]: Autosomal recessive disorder. Features of a severe
CC       phenotype, include elevated levels of formiminoglutamate (FIGLU)
CC       in the urine in response to histidine administration,
CC       megaloblastic anemia, and mental retardation. Features of a mild
CC       phenotype include high urinary excretion of FIGLU in the absence
CC       of histidine administration, mild developmental delay, and no
CC       hematological abnormalities. {ECO:0000269|PubMed:12815595}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the
CC       cyclodeaminase/cyclohydrolase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the
CC       formiminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169017; AAF15558.1; -; mRNA.
DR   EMBL; AF289021; AAG01852.1; -; mRNA.
DR   EMBL; AF289022; AAG01853.1; -; mRNA.
DR   EMBL; AF289023; AAG01854.1; -; mRNA.
DR   EMBL; AF289024; AAG01855.1; -; mRNA.
DR   EMBL; BC052248; AAH52248.2; -; mRNA.
DR   EMBL; BC136383; AAI36384.1; -; mRNA.
DR   EMBL; BC136395; AAI36396.1; -; mRNA.
DR   EMBL; U91541; AAD15627.1; -; mRNA.
DR   CCDS; CCDS13731.1; -. [O95954-1]
DR   CCDS; CCDS82684.1; -. [O95954-2]
DR   RefSeq; NP_001307341.1; NM_001320412.1. [O95954-2]
DR   RefSeq; NP_006648.1; NM_006657.2. [O95954-1]
DR   RefSeq; NP_996848.1; NM_206965.1. [O95954-1]
DR   UniGene; Hs.415846; -.
DR   ProteinModelPortal; O95954; -.
DR   SMR; O95954; -.
DR   BioGrid; 116053; 4.
DR   IntAct; O95954; 4.
DR   STRING; 9606.ENSP00000291670; -.
DR   DrugBank; DB03256; (6R)-Folinic acid.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   iPTMnet; O95954; -.
DR   PhosphoSitePlus; O95954; -.
DR   BioMuta; FTCD; -.
DR   MaxQB; O95954; -.
DR   PaxDb; O95954; -.
DR   PeptideAtlas; O95954; -.
DR   PRIDE; O95954; -.
DR   Ensembl; ENST00000291670; ENSP00000291670; ENSG00000160282. [O95954-1]
DR   Ensembl; ENST00000397746; ENSP00000380854; ENSG00000160282. [O95954-1]
DR   Ensembl; ENST00000397748; ENSP00000380856; ENSG00000160282. [O95954-2]
DR   GeneID; 10841; -.
DR   KEGG; hsa:10841; -.
DR   UCSC; uc002zif.3; human. [O95954-1]
DR   CTD; 10841; -.
DR   DisGeNET; 10841; -.
DR   GeneCards; FTCD; -.
DR   HGNC; HGNC:3974; FTCD.
DR   HPA; HPA020073; -.
DR   HPA; HPA030928; -.
DR   HPA; HPA030929; -.
DR   HPA; HPA036114; -.
DR   MalaCards; FTCD; -.
DR   MIM; 229100; phenotype.
DR   MIM; 606806; gene.
DR   neXtProt; NX_O95954; -.
DR   OpenTargets; ENSG00000160282; -.
DR   Orphanet; 51208; Formiminoglutamic aciduria.
DR   PharmGKB; PA28391; -.
DR   eggNOG; ENOG410IERX; Eukaryota.
DR   eggNOG; COG3404; LUCA.
DR   eggNOG; COG3643; LUCA.
DR   GeneTree; ENSGT00390000005581; -.
DR   HOVERGEN; HBG000168; -.
DR   InParanoid; O95954; -.
DR   KO; K13990; -.
DR   OMA; CEKENLF; -.
DR   OrthoDB; EOG091G0950; -.
DR   PhylomeDB; O95954; -.
DR   TreeFam; TF333892; -.
DR   BRENDA; 2.1.2.5; 2681.
DR   BRENDA; 4.3.1.4; 2681.
DR   Reactome; R-HSA-70921; Histidine catabolism.
DR   UniPathway; UPA00193; -.
DR   UniPathway; UPA00379; UER00555.
DR   ChiTaRS; FTCD; human.
DR   GenomeRNAi; 10841; -.
DR   PRO; PR:O95954; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000160282; -.
DR   CleanEx; HS_FTCD; -.
DR   ExpressionAtlas; O95954; baseline and differential.
DR   Genevisible; O95954; HS.
DR   GO; GO:0005814; C:centriole; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; ISS:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:BHF-UCL.
DR   GO; GO:0000139; C:Golgi membrane; IDA:BHF-UCL.
DR   GO; GO:0030868; C:smooth endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0005542; F:folic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0030412; F:formimidoyltetrahydrofolate cyclodeaminase activity; EXP:Reactome.
DR   GO; GO:0030407; F:formimidoyltransferase activity; ISS:BHF-UCL.
DR   GO; GO:0030409; F:glutamate formimidoyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008017; F:microtubule binding; IDA:BHF-UCL.
DR   GO; GO:0007010; P:cytoskeleton organization; IEA:Ensembl.
DR   GO; GO:0006760; P:folic acid-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0006548; P:histidine catabolic process; TAS:Reactome.
DR   GO; GO:0019556; P:histidine catabolic process to glutamate and formamide; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019557; P:histidine catabolic process to glutamate and formate; IEA:UniProtKB-UniPathway.
DR   GO; GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.30.70.670; -; 1.
DR   Gene3D; 3.30.990.10; -; 1.
DR   InterPro; IPR007044; Cyclodeamin/CycHdrlase.
DR   InterPro; IPR013802; Formiminotransferase_C.
DR   InterPro; IPR004227; Formiminotransferase_cat.
DR   InterPro; IPR012886; Formiminotransferase_N.
DR   InterPro; IPR022384; FormiminoTrfase_subdom.
DR   Pfam; PF02971; FTCD; 1.
DR   Pfam; PF04961; FTCD_C; 1.
DR   Pfam; PF07837; FTCD_N; 1.
DR   SMART; SM01221; FTCD; 1.
DR   SMART; SM01222; FTCD_N; 1.
DR   SUPFAM; SSF101262; SSF101262; 1.
DR   SUPFAM; SSF55116; SSF55116; 2.
DR   TIGRFAMs; TIGR02024; FtcD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Disease mutation; Folate-binding; Golgi apparatus;
KW   Histidine metabolism; Lyase; Multifunctional enzyme; Phosphoprotein;
KW   Polymorphism; Pyridoxal phosphate; Reference proteome; Transferase.
FT   CHAIN         1    541       Formimidoyltransferase-cyclodeaminase.
FT                                /FTId=PRO_0000087359.
FT   REGION        1    181       Formiminotransferase N-subdomain.
FT                                {ECO:0000250}.
FT   REGION      182    326       Formiminotransferase C-subdomain.
FT                                {ECO:0000250}.
FT   REGION      327    334       Linker. {ECO:0000250}.
FT   REGION      335    541       Cyclodeaminase/cyclohydrolase.
FT                                {ECO:0000250}.
FT   ACT_SITE     82     82       For formimidoyltransferase activity.
FT                                {ECO:0000250}.
FT   ACT_SITE    412    412       For cyclodeaminase activity.
FT                                {ECO:0000250}.
FT   MOD_RES     316    316       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     386    386       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     520    520       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88618}.
FT   VAR_SEQ     123    158       VYLYGEAARMDSRRTLPAIRAGEYEALPKKLQQADW -> G
FT                                LTAGLSCSLPVRRGSQDGQSPDPAGHPGRGVRGPP (in
FT                                isoform E).
FT                                {ECO:0000303|PubMed:10773664}.
FT                                /FTId=VSP_004257.
FT   VAR_SEQ     159    541       Missing (in isoform E).
FT                                {ECO:0000303|PubMed:10773664}.
FT                                /FTId=VSP_004258.
FT   VAR_SEQ     421    541       EAMRLPKNTPEEKDRRTAALQEGLRRAVSVPLTLAETVASL
FT                                WPALQELARCGNLACRSDLQVAAKALEMGVFGAYFNVLINL
FT                                RDITDEAFKDQIHHRVSSLLQEAKTQAALVLDCLETRQE
FT                                -> AHGGPTGGSEAGSLCAADAGGDGGLAVAGAAGTGPVWE
FT                                PGLPVRPPGGGQSPGDGRVWRIFQRAHQPEGHHRRGI (in
FT                                isoform D).
FT                                {ECO:0000303|PubMed:10773664}.
FT                                /FTId=VSP_004259.
FT   VAR_SEQ     514    541       IHHRVSSLLQEAKTQAALVLDCLETRQE -> PPAGSQDPG
FT                                CTGAGLLGDPAGVTVREASPGSVAPPSPIPRGQSCDLETPG
FT                                TAGPSTLEG (in isoform C).
FT                                {ECO:0000303|PubMed:10773664}.
FT                                /FTId=VSP_004260.
FT   VARIANT     135    135       R -> C (in FIGLU-URIA; mild phenotype;
FT                                61% wild-type activity;
FT                                dbSNP:rs28941768).
FT                                {ECO:0000269|PubMed:12815595}.
FT                                /FTId=VAR_015887.
FT   VARIANT     299    299       R -> P (in FIGLU-URIA; mild phenotype;
FT                                57% wild-type activity;
FT                                dbSNP:rs119469015).
FT                                {ECO:0000269|PubMed:12815595}.
FT                                /FTId=VAR_015888.
FT   VARIANT     438    438       A -> E. {ECO:0000269|PubMed:12815595}.
FT                                /FTId=VAR_015889.
SQ   SEQUENCE   541 AA;  58927 MW;  C6CFEBFC6DC2ED68 CRC64;
     MSQLVECVPN FSEGKNQEVI DAISGAITQT PGCVLLDVDA GPSTNRTVYT FVGPPECVVE
     GALNAARVAS RLIDMSRHQG EHPRMGALDV CPFIPVRGVS VDECVLCAQA FGQRLAEELD
     VPVYLYGEAA RMDSRRTLPA IRAGEYEALP KKLQQADWAP DFGPSSFVPS WGATATGARK
     FLIAFNINLL GTKEQAHRIA LNLREQGRGK DQPGRLKKVQ GIGWYLDEKN LAQVSTNLLD
     FEVTALHTVY EETCREAQEL SLPVVGSQLV GLVPLKALLD AAAFYCEKEN LFILEEEQRI
     RLVVSRLGLD SLCPFSPKER IIEYLVPERG PERGLGSKSL RAFVGEVGAR SAAPGGGSVA
     AAAAAMGAAL GSMVGLMTYG RRQFQSLDTT MRRLIPPFRE ASAKLTTLVD ADAEAFTAYL
     EAMRLPKNTP EEKDRRTAAL QEGLRRAVSV PLTLAETVAS LWPALQELAR CGNLACRSDL
     QVAAKALEMG VFGAYFNVLI NLRDITDEAF KDQIHHRVSS LLQEAKTQAA LVLDCLETRQ
     E
//
